Zacks Investment Research upgraded shares of Udg Healthcare (OTCMKTS:UDHCF) from a hold rating to a buy rating in a report released on Tuesday. Zacks Investment Research currently has $14.00 target price on the stock.
According to Zacks, “UDG Healthcare plc provide services to the healthcare industry. The company’s operating segment consists of Ashfield Commercial & Medical Services, Sharp Packaging Services and Supply Chain Services. Ashfield Commercial & Medical Services division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services. Sharp Packaging Service division provides contract packaging and clinical trial packaging services. Supply Chain Services provides outsourced sales, marketing, distribution and engineering services. UDG Healthcare plc operates primarily in US, UK, Ireland and Germany. UDG Healthcare plc is based in Dublin, the Republic of Ireland. “
Shares of OTCMKTS UDHCF opened at $12.35 on Tuesday. Udg Healthcare has a fifty-two week low of $10.85 and a fifty-two week high of $12.65.
About Udg Healthcare
UDG Healthcare plc, together with its subsidiaries, provides clinical, commercial, communication, and packaging services to the healthcare industry in the Republic of Ireland, the United Kingdom, North America, and continental Europe. It operates through three segments: Ashfield, Sharp, and Aquilant.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.